Abstract
In this prospective study, we monitored 4 epidemiologically important pathogens (EIPs): methicillin-resistane Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), Clostridium difficile, and multidrug-resistant (MDR) Acinetobacter to assess the effectiveness of 3 enhanced disinfection strategies for terminal room disinfection against standard practice. Our data demonstrated that a decrease in room contamination with EIPs of 94% was associated with a 35% decrease in subsequent patient colonization and/or infection.
Trial registration:
ClinicalTrials.gov NCT01579370.
Publication types
-
Multicenter Study
-
Pragmatic Clinical Trial
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Acinetobacter / isolation & purification
-
Acinetobacter / radiation effects
-
Clostridioides difficile / isolation & purification
-
Clostridioides difficile / radiation effects
-
Cross Infection / microbiology*
-
Cross Infection / prevention & control*
-
Disinfection / methods*
-
Environmental Microbiology*
-
Humans
-
Methicillin-Resistant Staphylococcus aureus / isolation & purification
-
Methicillin-Resistant Staphylococcus aureus / radiation effects
-
Patients' Rooms / standards*
-
Prospective Studies
-
Ultraviolet Rays
-
United States
-
Vancomycin-Resistant Enterococci / isolation & purification
-
Vancomycin-Resistant Enterococci / radiation effects
Associated data
-
ClinicalTrials.gov/NCT01579370